Objective: With the aim of improving early detection of pancreatic carcinoma, we attempted to make correlations among positive immunohistochemical detection of p53 expression, mutations in the p53 gene, and detailed histologic features of pancreatic carcinoma.
Methods: Seven cases of invasive pancreatic ductal carcinoma demonstrating p53 overexpression were analyzed. Serial 4- and 20-microm sections from paraffin blocks were used for immunodetection of p53 protein and microdissection, respectively. We used direct sequencing of polymerase chain reaction at 101 p53-positive and 10 p53-negative sites to sequence exons 5 to 8 of p53 and then analyzed these results in concert with detailed histologic features.
Results: Regardless of the degree of p53 overexpression, we detected p53 point mutations in all p53-positive lesions, including 22 noninvasive sites, 17 invasive areas, and 1 lymph node metastasis. No significant correlations were measured between specific p53 mutations and histologic features. Within individual tumors, the same p53 mutation was generally, but not always, detected in different areas in invasive and noninvasive lesions.
Conclusions: Our results demonstrate that p53 mutation is an early genetic event affecting a diversity of molecular pathways in pancreatic carcinogenesis and indicates a possibility of early diagnosis of pancreatic carcinoma by detecting a few p53-positive cells obtained from the pancreatic fluid.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/mpa.0b013e318197a3f5 | DOI Listing |
Front Immunol
January 2025
Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Objective: This study aimed to investigate the diagnostic value of 7-tumor associated autoantibodies (7-TAAB) and to evaluate the relationship between 7-TAAB and clinical features in esophageal squamous cell carcinoma (ESCC), which can be used to guide clinical diagnosis and treatment and achieve its clinical value.
Methods: (1) Blood specimens were collected from patients with ESCC who had not previously received antitumor therapy (ESCC group) and those who had normal medical check-ups in the hospital during the same period (control group). The concentrations of 7-TAAB (P53, PGP9.
Front Immunol
January 2025
Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Background: Radical cystectomy (RC) combined with pelvic lymph node dissection (PLND) is the standard treatment for muscle-invasive bladder cancer (MIBC). For metastatic MIBC patients, platinum-based chemotherapy remains the first choice treatment. However, approximately 50% of patients with metastatic MIBC are ineligible for platinum-based adjuvant chemotherapy because of impaired renal function.
View Article and Find Full Text PDFTheranostics
January 2025
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan Province, People's Republic of China.
Dysfunctional tumor vasculature, hypoxia, and an immunosuppressive microenvironment are significant barriers to effective cancer therapy. Autophagy, which is critical for maintaining cellular homeostasis and apoptosis resistance, is primarily triggered by hypoxia and nutrient deprivation, conditions prevalent in dysfunctional tumor vessels due to poor circulation. However, the role of autophagy in dysfunctional tumor endothelial cells and its impact on treatment and the tumor microenvironment (TME) remain poorly understood.
View Article and Find Full Text PDFFront Cell Dev Biol
December 2024
Department of General Surgery, Nanchang Third Hospital, Nanchang, Jiangxi, China.
PCAT19, a long non-coding RNA, has attracted considerable attention due to its diverse roles in various malignancies. This work compiles current research on PCAT19's involvement in cancer pathogenesis and progression. Abnormal expression of PCAT19 has been observed in various cancers, and its correlation with clinical features and prognosis positions it as a promising prognostic biomarker.
View Article and Find Full Text PDFHistol Histopathol
October 2024
Department of Pathology, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Introduction: Appendiceal mucinous neoplasms (AMNs) represent a rare and diagnostically challenging group of tumors. This systematic review aims to summarize the reported molecular and immunohistochemical markers (IHC) associated with AMNs and compare them with ovarian mucinous neoplasms (OMNs) and colorectal adenocarcinoma (CRC).
Methods: A comprehensive search was performed in PubMed/MEDLINE/PMC, Scopus, Embase, and Web of Science databases to identify studies looking at IHC and molecular markers in AMNs.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!